AbbVie Inc. Proceeds from Stock Issuance 2013-2025 | ABBV
Beta
What is AbbVie Inc.'s current proceeds from stock issuance?
AbbVie Inc. (ABBV) annual proceeds from stock issuance for 2025 was $172.0M, a 19.63% decline from 2024. AbbVie Inc. proceeds from stock issuance for the quarter ending December 31, 2025 was $48.0M.
What was AbbVie Inc.'s proceeds from stock issuance in 2024?
AbbVie Inc. annual proceeds from stock issuance for 2024 was $214.0M, a 18.89% increase from 2023.
What was AbbVie Inc.'s proceeds from stock issuance in 2023?
AbbVie Inc. annual proceeds from stock issuance for 2023 was $180.0M, a 31.30% decline from 2022.
What is AbbVie Inc.'s 5-year proceeds from stock issuance CAGR?
AbbVie Inc. proceeds from stock issuance grew at a compound annual growth rate (CAGR) of 3.82% from FY2020 to FY2025, going from $209.0M to $172.0M over 5 years.
Proceeds from Stock Issuance History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-3.8%
FY2020
$209.0M
→
FY2025
$172.0M
13141516171819202122232425
5 years selected
Proceeds from Stock Issuance History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $172.0M | -19.6% | 10-K |
| FY2024 | $214.0M | +18.9% | 10-K |
| FY2023 | $180.0M | -31.3% | 10-K |
| FY2022 | $262.0M | +7.4% | 10-K |
| FY2021 | $244.0M | +16.7% | 10-K |
| FY2020 | $209.0M | +2512.5% | 10-K |
| FY2019 | $8.0M | -89.0% | 10-K |
| FY2018 | $73.0M | -71.3% | 10-K |
| FY2017 | $254.0M | -5.2% | 10-K |
| FY2016 | $268.0M | +72.9% | 10-K |
| FY2015 | $155.0M | -33.2% | 10-K |
| FY2014 | $232.0M | -33.1% | 10-K |
| FY2013 | $347.0M | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →